Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2000
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000WO2000016765A9 Method and composition for treatment of inflammatory bowel disease
10/05/2000WO2000011167A3 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
10/05/2000WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies
10/05/2000WO1999053951A9 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368760A1 Flint polypeptide analogs
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368442A1 48 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1040838A1 Stable aqueous EM 12 solution
10/04/2000EP1040833A1 Bone resorption suppressing agent
10/04/2000EP1040829A2 Prokinetic agents for treating gastric hypomotility and related disorders
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040097A1 Potassium channel openers
10/04/2000EP1039922A1 Improved interferon polymer conjugates
10/04/2000EP1039916A2 Use of fucane for regulating the reconstruction of connective tissues
10/04/2000EP1039911A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS
10/04/2000EP1039910A1 Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
10/04/2000EP1039905A1 Pharmaceutical formulation comprising glycine as a stabilizer
10/04/2000EP1039904A1 Synergistic antimicrobial compositions
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039898A1 Compositions comprising cannabinoids
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039892A2 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
10/04/2000EP1039804A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
10/04/2000EP0812181B1 Composition for hygiene, prophylaxis and treatment of the oral cavity
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof
10/04/2000EP0690719B1 Dry mix formulation for bisphosphonic acids
10/04/2000CN1268938A Aminocycloalkane compounds
10/04/2000CN1268884A Intra-oral antioxidant prepns.
10/04/2000CN1268363A Medicine for curing hepatitis B and its preparation method
10/04/2000CN1268362A Compound Chinese herb medicine for curing fibrosis of liver and hepatocirrhosis and its preparation method
10/04/2000CN1268358A Stomach-nourishing mixture
10/04/2000CN1268357A Fat-reducing liver-fortifying mixture
10/04/2000CN1268356A Medicine for curing children insulfficiency of the spleen and anorexia and its preparation method
10/04/2000CN1268354A Chinese patent medicine for curing gastric ulcer
10/04/2000CN1268352A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole
10/04/2000CN1057083C Tricyclic 1-aminoethylpyrrol derivative
10/04/2000CN1057011C Traditional Chinese medicine for regulating taste, beneifitting liver and kidney and improving intelligence
10/04/2000CN1057000C Application of theaflavine for prepn. of medicine for treating fatty liver
10/04/2000CN1056998C Traditional Chinese medicine bolus for treating bone tuberculosis and prepn. method therefor
10/04/2000CN1056996C Application of theaflavine for prepn. of medicine for treating helicobacter pylori related disease
10/03/2000US6127544 1-substituted-3-ureido-indolin-2-ones which exhibit selective antagonism against gastrin receptors without causing side effects attributed to cck-a receptor antagonism; such as for treatment of peptic ulcers, gastritis
10/03/2000US6127542 Chemical intermediates to specified pyrazino(2',1':6,1)pyrido(3,4b)indole-1,4-diones which are selective inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase; to treat cardiovascular disorders
10/03/2000US6127423 Phenylamidine derivatives, a process for preparing the same and their use as medicaments
10/03/2000US6127408 Thioether furan nitrone compounds; nervous system degenerative disorders, e.g. alzheimer's disease; analysis of free radicals by forming adducts; inhibit the forming of a beta(1-42) beta-pleated sheets and/or suppressing cytokines
10/03/2000US6127389 Benzimidazole derivatives as bradykinin agonists
10/03/2000US6127382 An antiproliferative agent for treating skin-related diseases, an antitumor agent treating cancer, an antiinflammatory agent treating pulmonary fibrosis, ileitis, colitis and krohn's disease
10/03/2000US6127367 Administering an aldose reductase inhibitor as an antiischemic agent
10/03/2000US6127365 Tachykinin antagonists for treatment of pain, inflammation, migraine, emesis and postherpetic neuralgia.
10/03/2000US6127361 5,11-dihydrodibenzo[b,e][1,4]oxazepine derivatives and pharmaceutical compositions containing the same
10/03/2000US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof
10/03/2000US6126970 Coating of polyvinyl chloride or terpolymer of vinyl chloride, vinyl acetate and vinyl alcohol with pores for water soluble or gastrointestinal fluids
10/03/2000US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof
10/03/2000CA2206463C Silicone compositions
09/2000
09/30/2000CA2302886A1 A stable aqueous solution of em 12
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof
09/28/2000WO2000056862A1 Human tumor necrosis factor receptor tr9
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056752A2 Apoptosis related genes
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056737A2 Calanolides for inhibiting btk
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056728A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056727A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056718A1 Imidazole compounds
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056349A1 Treatment with small peptides to effect antifibrotic activity
09/28/2000WO2000056344A1 Artificial saliva
09/28/2000WO2000056343A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/28/2000WO2000056337A1 Agents for relieving side effects
09/28/2000WO2000056331A1 Inhibitors of impdh enzyme
09/28/2000WO2000056323A1 Treatment of certain cancers associated with weight gain
1 ... 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 ... 1258